PhoreMost: Neil Torbett, CEO
Biopharmaceutical company PhoreMost has promoted Neil Torbett from COO to CEO; founder and former CEO Chris Torrance will become chair of the company’s board. Before joining PhoreMost in 2017, Torbett co-founded proteomics company Activiomics and worked at Piramed Pharma.
Torrance said, “Neil’s invaluable expertise and guidance as COO has been key to PhoreMost’s great progress over the last few years. He is a huge asset to the company and as CEO, I know that he will continue to shape PhoreMost as a fully integrated target identification and drug discovery company.”